Fig. 2

Effect of different flaxseed products on net changes (95% CI) of a TC/HDL-C, b apo A, c apo B and d apo A/apo B in patients with dyslipidemia related diseases; (1) and (2) represent the low dose and high dose in two studies (Zhang et al. and Fukumitsu et al. respectively); a and b represent brown and golden flaxseed interventions respectively in the study by Machado et al.; (I) and (II) represent short and long intervention time respectively in the study by Bloedon et al.